Loading...
•
May 31, 2025
Walgreens Q3 2025 Earnings Report
Walgreens reported Q3 results with a net loss and lower adjusted EPS driven by higher taxes and weaker retail sales.
Key Takeaways
Walgreens delivered $39.0B in revenue for Q3 2025, growing year-over-year. However, it posted a net loss of $175M due to prior year gains not recurring and higher tax expenses. Adjusted EPS dropped to $0.38 as cost savings were offset by weaker retail sales and lower equity earnings.
Q3 revenue grew 7.2% year-over-year to $39.0B
Reported a net loss of $175M vs. net income of $344M in Q3 2024
Adjusted EPS declined to $0.38 from $0.63
Free cash flow remained positive at $336M
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Fiscal 2025 guidance remains withdrawn due to the pending Sycamore Partners acquisition.
Positive Outlook
- Improved U.S. Healthcare adjusted operating income
- Continued cost savings in U.S. Retail Pharmacy
- Boots.com sales grew 18.7%
- Free cash flow remained positive
- Shields and CareCentrix showed sales growth
Challenges Ahead
- U.S. retail sales declined
- Higher tax expenses impacted earnings
- Lower equity earnings in Cencora
- No forward guidance provided
- Net loss driven by lack of prior-year one-time gains
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...